Rituximab as first-line therapy for acquired haemophilia A: a single-centre 10-year experience.

Haemophilia

Department of Internal Medicine, National Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Université Paris Descartes, Paris, France.

Published: July 2016

Download full-text PDF

Source
http://dx.doi.org/10.1111/hae.12973DOI Listing

Publication Analysis

Top Keywords

rituximab first-line
4
first-line therapy
4
therapy acquired
4
acquired haemophilia
4
haemophilia single-centre
4
single-centre 10-year
4
10-year experience
4
rituximab
1
therapy
1
acquired
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!